|
| 1. | (2) Selective serotonin reuptake inhibitors APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Second Edition > Part B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Acute Phase Somatic Treatments > 1. Antidepressant medications > c) Side effects |
|
| 2. | (2) Selective serotonin reuptake inhibitors APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Second Edition > Part B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Acute Phase Somatic Treatments > 1. Antidepressant medications > b) Efficacy |
|
| 3. | (i) Treatment of affective dysregulation symptoms APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Borderline Personality Disorder > Part A: Treatment Recommendations for Patients With Borderline Personality Disorder > I. Executive Summary of Recommendations > C. Summary of Recommendations > 4. Specific treatment strategies > b) Pharmacotherapy and other somatic treatments |
|
| 4. | Manage medication side effects. APA Practice Guidelines > TREATING OBSESSIVE-COMPULSIVE DISORDER: A Quick Reference Guide > C. Implementation of Treatment |
|
| 5. | 1. Psychopharmacology APA Practice Guidelines > TREATING PATIENTS WITH ACUTE STRESS DISORDER AND POSTTRAUMATIC STRESS DISORDER: A Quick Reference Guide > D. Specific Treatment Strategies |
|
| 6. | 1. Selective serotonin reuptake inhibitors APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Panic Disorder, Second Edition > Part A. Treatment Recommendations > II. Formulation and Implementation of a Treatment Plan > H. Specific Pharmacological Interventions |
|
| 7. | 1. Selective serotonin reuptake inhibitors APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Panic Disorder, Second Edition > Part B. Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > C. Pharmacological Interventions |
|
| 8. | 1. Side effects APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Panic Disorder, Second Edition > Part B. Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > C. Pharmacological Interventions > 1. Selective serotonin reuptake inhibitors > b. Implementation issues |
|
| 9. | 1. SSRI antidepressants APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Borderline Personality Disorder > Part B: Background Information and Review of Available Evidence > VI. Review and Synthesis of Available Evidence > C. Review of Pharmacotherapy and Other Somatic Treatments |
|
| 10. | 2. Choosing a Specific Pharmacological Treatment APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder > Part A. Treatment Recommendations > II. Formulation and Implementation of a Treatment Plan > B. Acute Phase |
|
| 11. | 2. Efficacy of SSRIs APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder > Part B. Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Medications |
|
| 12. | 3. Pharmacotherapy and Other Somatic Treatments APA Practice Guidelines > TREATING BORDERLINE PERSONALITY DISORDER: A Quick Reference Guide > D. Specific Treatment Strategies |
|
| 13. | 4. SSRIs and other newer antidepressant agents APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Bipolar Disorder Second Edition > PART B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > B. Somatic Treatments of Acute Depressive Episodes |
|
| 14. | A range of specific psychosocial and pharmacological interventions have proven benefits in... APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Panic Disorder, Second Edition > Part A. Treatment Recommendations > I. Executive Summary > C. Formulation and Implementation of a Treatment Plan > 2. Choosing an initial treatment modality |
|
| 15. | A range of specific psychosocial and pharmacological interventions have proven benefits in... APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Panic Disorder, Second Edition > Part A. Treatment Recommendations > II. Formulation and Implementation of a Treatment Plan > C. Choosing an Initial Treatment Modality |
|
| 16. | a) SSRIs APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Acute Stress Disorder and Posttraumatic Stress Disorder > Part A: Treatment Recommendations > II. Formulation and Implementation of a Treatment Plan > D. Specific Treatment Strategies > 1. Psychopharmacology |
|
| 17. | a) SSRIs APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Acute Stress Disorder and Posttraumatic Stress Disorder > Part B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > C. Pharmacotherapies > 1. Antidepressants |
|
| 18. | a) SSRIs APA Practice Guidelines > Practice Guideline for the Treatment of Patients With HIV/AIDS > PART B: Review and Synthesis of Available Evidence > VI. Data Regarding Psychiatric Treatments for Individuals With HIV Infection > B. Pharmacologic Treatment > 1. Antidepressant agents |
|
| 19. | a) Treatment of affective dysregulation symptoms APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Borderline Personality Disorder > Part A: Treatment Recommendations for Patients With Borderline Personality Disorder > II. Formulation and Implementation of a Treatment Plan > D. Specific Treatment Strategies for the Clinical Features of Borderline Personality Disorder > 2. Pharmacotherapy and other somatic treatments |
|
| 20. | a. Efficacy APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Panic Disorder, Second Edition > Part B. Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > C. Pharmacological Interventions > 1. Selective serotonin reuptake inhibitors |
|